Surgery may be best for advanced melanoma

April 5, 2017

(HealthDay)—Surgery to remove melanoma—the deadliest form of skin cancer—can extend the lives of patients whose disease has spread to the abdomen area, new research suggests.

Patients who get and to remove their cancer live twice as long—18 months on average—as those who only get medication, researchers found.

"Now that there are better options systemically, the decision-making about treatment has become more complex. Having this data available could potentially impact discussions about treatment and benefit long-term," said study leader Dr. Gary Deutsch, a cancer surgeon at Northwell Health in Great Neck, N.Y.

"I think the combination of immunotherapy with surgical therapy ... could potentially lead to curing more patients," he said in a health system news release.

Immunotherapy prompts a patient's immune system to destroy cancer cells. The U.S. Food and Drug Administration has approved it to treat melanoma, providing an alternative to standard chemotherapy for cancers that spread to other parts of the body. The researchers behind the new study said surgery to remove melanoma that has spread within the belly is rare.

For the study, Deutsch and his team analyzed the medical records of more than 1,600 patients treated for melanoma that had spread to the abdominal area. Of those, nearly 400 had surgery to remove their cancer.

Melanoma had spread to the liver in 697 patients, to the gastrointestinal tract in 336 patients and to the adrenal glands in 138 patients. It spread to the spleen in 109 patients and to the pancreas in 38. Another 305 patients' spread to several organs.

For patients who had surgery to remove their , the average survival time was 18 months, nearly 2.5 times longer than those who didn't have surgery.

The study was published April 5 in the journal JAMA Surgery.

Deutsch said he believes integrating surgery with newer drug treatments will greatly benefit patients.

Deutsch did the research as a surgical oncology fellow at the John Wayne Cancer Institute at Providence Saint John's Health Center in Santa Monica, Calif.

Explore further: Surgery on that has spread into abdomen more than doubles patient survival time

More information: The American Cancer Society provides more information on melanoma.

Related Stories

Surgery on that has spread into abdomen more than doubles patient survival time

October 8, 2015
Patients with metastatic melanoma who undergo surgery to remove lesions that have spread into the abdomen live more than twice as long as those treated with drug therapy alone, according to novel new research by a North Shore-LIJ ...

Liver tumor growth in mice slowed with new chemo-immunotherapy treatment

February 28, 2017
Hepatocellular carcinoma is the most common form of liver cancer, but treatment options are limited and many patients are diagnosed in late stages when the disease can't be treated. Now, University of Missouri School of Medicine ...

When breast cancer spreads to lungs, surgery may increase survival

April 1, 2013
(HealthDay)—Patients with breast cancer that has spread to the lungs may live longer if they have surgery to remove the lung tumors, a new study from Germany suggests.

Melanoma surgery delays are common for Medicare patients

April 8, 2015
One in five Medicare patients with melanoma experience delays in getting surgery, a Yale study found. The research was published April 8 in JAMA Dermatology.

Researchers find immunotherapy treatments better for advanced skin cancer

November 4, 2016
McMaster University researchers have found that for patients diagnosed in the late stages of one of the most common and deadly forms of skin cancer, treatment with a combination of immunotherapy options improves survival ...

Research providing promising new treatments for melanoma

December 6, 2016
In a paper published online November 30, 2016, in Melanoma Management, Adam Riker, MD, Professor of Surgery and Chief of Surgical Oncology at LSU Health New Orleans School of Medicine, reviews approaches to manage melanoma, ...

Recommended for you

Researchers decipher the genome in chronic lymphocytic leukaemia

May 23, 2018
A team of researchers from University of Barcelona (UB) and their collaborators report for the first time the complete epigenome of chronic lymphocytic leukaemia, the most common type of leukaemia. The study, published in ...

Scientists discover how breast cancer hibernates: study

May 22, 2018
Scientists have identified the mechanism that allows breast cancer cells to lie dormant in other parts of the body only to reemerge years later with lethal force, according to a study published Tuesday.

Researcher: Big data, networks identify cell signaling pathways in lung cancer

May 22, 2018
A team of scientists led by University of Montana cell biologist Mark Grimes has identified networks inside lung cancer cells that will help understand this cancer and fight it with drug treatments.

Resetting the epigenetic balance for cancer therapy

May 22, 2018
Though mutations in a gene called MLL3 are common across many types of cancers, their relationship to the development of the disease has been unclear. Now, a Northwestern Medicine study has identified an epigenetic imbalance ...

Downward-facing mouse: Stretching reduces tumor growth in mouse model of breast cancer

May 22, 2018
Many cancer patients seek out gentle, movement-based stretching techniques such as yoga, tai chi and qigong, but does stretching have an effect on cancer? While many animal studies have attempted to quantify the effects of ...

Compound in citrus oil could reduce dry mouth in head, neck cancer patients

May 21, 2018
A compound found in citrus oils could help alleviate dry mouth caused by radiation therapy in head and neck cancer patients, according to a new study by researchers at the Stanford University School of Medicine.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.